期刊文献+

非水滴定法测定帕拉米韦原料药中帕拉米韦 被引量:5

Determination of peramivir in peramivir bulks drug by nonaqueous titration
原文传递
导出
摘要 目的建立帕拉米韦三水合物原料药中帕拉米韦的测定方法。方法以0.1mol/L高氯酸溶液为滴定液,以冰醋酸为溶剂,采用非水滴定法进行测定。结果帕拉米韦样品溶液6h内稳定;重复性测定结果表明RSD值为0.07%(n=6)。结论该方法简单、准确,具有良好的重复性和稳定性,可作为帕拉米韦原料药的测定方法,为帕拉米韦的质量控制提供科学依据。 Objective To establish a method for the determination of peramivir in peramivir bulk drug.Methods The contents were performed by nonaqueous titration method with 0.1 mol/L perchloric acid solution as titrant and with glacial acetic acid as solvent.Results Peramivir sample solution was stable within 6 h.Relative standard deviation(RSD) of repeatability was 0.07%(n=6).Conclusion The established method is simple and accurate with good repeatability,which could be applied for the determination of peramivir bulk drug and provide the scientific evidence for the quality control of peramivir bulk drug.
出处 《现代药物与临床》 CAS 2013年第2期200-202,共3页 Drugs & Clinic
关键词 帕拉米韦原料药 帕拉米韦 高氯酸 非水滴定 peramivir bulk drug peramivir perchloric acid nonaqueous titration
  • 相关文献

参考文献5

二级参考文献17

  • 1郭文玉,诸骏仁,江文德,李志善,陈秋潮,杨金铭.用高效液相色谱法测定莫雷西嗪及其代谢产物在血及尿中的浓度[J].药物分析杂志,1995,15(1):7-10. 被引量:9
  • 2AKIYOSHI H,HISAO M,KAZUYASU M,et al.Ranolazine:an antiischemic drug with a novel mechanism of action.cardiovascular drug with a novel mechanism of action[J].Cardiovascular Drug Rewiew,1999,17(1):58 -74.
  • 3ALLEY M C,ALPS B J N,KILPATRICK A T.The effects of the novel anti-anginal RS43285 on[lactic acid],[k +] and pH in a canine model of transient my ocardial ischaemia[J].Biochem Soc Trans,1987,15(6):1057-1058.
  • 4MCCORMACK J G,BARR R L,WOLFF A A,et al.Ranolazine stimulates glucose oxidation in normoxic ischemic and reperfusion ischemicrat hearts[J].Circulation,1996,93 (1):135-142.
  • 5WANG J X,MARUYAMA K,MURAKAMI M,et al.Antianginal effects of ranolazine in various experimental models of angina[J].Arzneimit telforschung,1999,49 (2):193-199.
  • 6刘文英.药物分析[M].5版.北京:人民卫生出版社,2004:189-192.
  • 7Chand P, Kotian P L, Dehghani A, et al. Systematic structure-base design and stereoselective synthesis of novel multisubstituted cyclopentane derivatives with potent antiinfluenza activity [J]. J Med Chem, 2001, 44(25): 4379-4392.
  • 8Mineno T, Miller M J. Stereoselective total synthesis of racemic BCX-1812 (RWJ-270201) for the development of neuraminidase inhibitors as anti-influenza agents. [EB/OL]. [2003-06-10]. http://pubs.acs.org/doi/suppl/ 10.1021/Jo034316b/suppl_file/j o034316bsi20030610_ 122 637.pdf.
  • 9Keller E, Kramer V. Crystal structure of the trihydrate of the neuraminidase inhibitor CIsH28N404 (Peramivir), a potential influenza A/B and avian-influenza (H5N1) drug [J]. Z Naturforsch B, 2007, 62b: 983-987.
  • 10US Centers for Disease Control and Prevention.Update:drug susceptibility of swine-origin influenza A(H1N1)viruses[].Morbidity and Mortality Weekly Report.2009

共引文献73

同被引文献30

  • 1胡宏岗,张俊,赵庆杰,赵惠清,吴秋业.盐酸米多君的合成工艺改进[J].中国医药工业杂志,2006,37(7):445-446. 被引量:2
  • 2徐克功,胡永萍.紫外分光光度法测定痢菌净注射液的含量[J].云南农业,2007(1):38-39. 被引量:2
  • 3冯俊贤,宋丽英,张如春,李新伟.新的电位滴定终点识别方法[J].理化检验(化学分册),2007,43(5):400-402. 被引量:2
  • 4国家质量技术监督局,测量不确定度评定与表示JJF1059-1999[S].北京:中国计量出版社,1999
  • 5中国药典2010年版二部附录[s].
  • 6中国合格评定国家认可委员会.化学分析中不确定度的评估指南CNAS-GL06 [S].北京:中国计量出版社,2006:6-38.
  • 7国家质量监督检验检疫总局.常用玻璃量器检定规程JJG196-2006[S].北京:中国计量出版社,2006 : 6-8.
  • 8国家质量技术监督局.中华人民共和国国家计量检定规程:容量仪器[S].北京:中国标准出版社,2000 : 4-6.
  • 9Michael EW, Norman H,Tyler BC, et al. Atomic wei-ghts of the elements 2011[J]. Pure Appl Ckem,2013,85(5):1 047.
  • 10中国药典[S].2015年版二部,附录.

引证文献5

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部